Nantahala Capital Management LLC Takes Position in Inspire Medical Systems, Inc. $INSP

Nantahala Capital Management LLC acquired a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) in the second quarter, Holdings Channel reports. The fund acquired 269,474 shares of the company’s stock, valued at approximately $12,021,235.

A number of other institutional investors have also recently added to or reduced their stakes in INSP. BlackRock Inc. bought a new stake in Inspire Medical Systems in the second quarter valued at $211,341,000. Wellington Management Group LLP bought a new position in shares of Inspire Medical Systems during the fourth quarter worth about $203,929,000. Deerfield Management Company L.P. grew its position in shares of Inspire Medical Systems by 648.4% during the third quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock worth $77,739,000 after acquiring an additional 907,694 shares during the last quarter. Morgan Stanley increased its holdings in shares of Inspire Medical Systems by 179.5% in the 4th quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock worth $116,188,000 after acquiring an additional 809,121 shares during the period. Finally, Fuller & Thaler Asset Management Inc. acquired a new stake in shares of Inspire Medical Systems in the 4th quarter worth about $61,619,000. 94.91% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on INSP shares. JPMorgan Chase & Co. raised their price target on shares of Inspire Medical Systems from $54.00 to $60.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Zacks Research raised Inspire Medical Systems from a “hold” rating to a “strong-buy” rating in a report on Monday, August 17th. Mizuho raised their target price on Inspire Medical Systems from $55.00 to $65.00 and gave the company an “outperform” rating in a research report on Tuesday, August 4th. Bank of America downgraded Inspire Medical Systems from a “neutral” rating to an “underperform” rating and set a $39.00 target price on the stock. in a research note on Friday, May 22nd. Finally, Stifel Nicolaus set a $75.00 price target on Inspire Medical Systems in a research report on Tuesday, August 4th. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $66.19.

Inspire Medical Systems Trading Up 1.1%

Inspire Medical Systems stock opened at $61.49 on Friday. The stock has a market cap of $1.78 billion, a price-to-earnings ratio of 13.31, a PEG ratio of 4.62 and a beta of 0.70. The company’s 50-day moving average price is $53.10 and its two-hundred day moving average price is $52.50. Inspire Medical Systems, Inc. has a 52 week low of $38.91 and a 52 week high of $147.03.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The business had revenue of $200.58 million during the quarter, compared to analyst estimates of $194.72 million. During the same quarter in the prior year, the firm posted $0.45 earnings per share. The company’s revenue was down 7.6% on a year-over-year basis. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Research analysts expect that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current fiscal year.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, insider Jason P. Kelly sold 963 shares of Inspire Medical Systems stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $59.55, for a total value of $57,346.65. Following the transaction, the insider owned 18,985 shares in the company, valued at approximately $1,130,556.75. The trade was a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 2.20% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.